Novartis Unbranded Hypertension Ad Cited For Link To Diovan Promotion

Novartis has had two conference calls with FDA's Division of Drug Marketing, Advertising & Communications to discuss the agency's concerns about unbranded ads connected with the company's direct-to-consumer Diovan (valsartan) campaign